Sensex
72,472.33 profit arw 879.09 (1.23%)
Nifty
22,520.45 profit arw 288.65 (1.30%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below

As on : 08-Oct-2026
Hot Pursuit
08-Oct-2026     20:13

Evonile Pharma plans to raise up to Rs 9,000 million through a rights issue

Evonile Pharma Limited (formerly Novartis India Limited) plans to raise up to Rs 9,000 million through a rights issue of partly paid-up equity shares with a face value of Rs 5 each, to be offered to eligible shareholders on a record date to be determined later, subject to statutory and regulatory approvals. The company has constituted a Rights Issue Committee to finalize the issue details, including the rights entitlement ratio and issue price, and the total number of securities to be issued will be determined at a later date. The board also approved a postal ballot notice for shareholder approval and the launch of a new corporate website at www.evonilepharma.com.

INDIAN INDICES

Sensex

72,472.33 879.09 (1.23%)

Nifty

22,520.45 288.65 (1.30%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

24,160.15 374.35(1.57%)